UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial

The American journal of psychiatry, 2005-07, Vol.162 (7), p.1281-1290

2005

Volltextzugriff (PDF)

Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss

Thrombosis and haemostasis, 2004-04, Vol.91 (4), p.694-699

2004

Volltextzugriff (PDF)

Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients

International clinical psychopharmacology, 2005-01, Vol.20 (1), p.19-21

2005

Volltextzugriff (PDF)

An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms

The journal of clinical psychiatry, 2001, Vol.62 Suppl 2, p.25

2001

Volltextzugriff (PDF)

Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone

The journal of clinical psychiatry, 2001, Vol.62 Suppl 2, p.28

2001

Volltextzugriff (PDF)

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method

Journal of the European Academy of Dermatology and Venereology, 2021-05, Vol.35 (5), p.1161-1175

2021

Volltextzugriff (PDF)

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients

International journal of clinical practice (Esher), 2009-11, Vol.63 (11), p.1578-1588

2009

Volltextzugriff (PDF)

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

Progress in neuro-psychopharmacology & biological psychiatry, 2004, Vol.28 (1), p.173-180

2004

Volltextzugriff (PDF)

336 Matching-adjusted indirect comparisons of Ixekizumab and Secukinumab using Etanercept and Ustekinumab Bridge Comparators

Journal of investigative dermatology, 2017-05, Vol.137 (5), p.S58-S58

2017

Volltextzugriff (PDF)

Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia

Progress in neuro-psychopharmacology & biological psychiatry, 2004-03, Vol.28 (2), p.311-318

2004

Volltextzugriff (PDF)

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol

The journal of clinical psychiatry, 2004-03, Vol.65 (3), p.312-321

2004

Volltextzugriff (PDF)

Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study

International journal of clinical practice (Esher), 2009-07, Vol.63 (7), p.1041-1049

2009

Volltextzugriff (PDF)

Specificity of FGF signaling in cell migration in Drosophila

Development (Cambridge), 2001-11, Vol.128 (22), p.4563-4572

2001

Volltextzugriff (PDF)

The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine

Clinical therapeutics, 2000-09, Vol.22 (9), p.1021-1034

2000

Volltextzugriff (PDF)

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study

International journal of psychiatry in clinical practice, 2011-06, Vol.15 (2), p.80-90

2011

Volltextzugriff (PDF)

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

International journal of geriatric psychiatry, 2001-12, Vol.16 (S1), p.S33-S61

2001

Volltextzugriff (PDF)

P.3.e.003 The relative association between four treatment-emergent adverse events and health-related quality of life

European neuropsychopharmacology, 2009, Vol.19, p.S568-S569

2009

Volltextzugriff (PDF)

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients: W-SOHO: observational database of more than 17,000 patients

International journal of clinical practice (Esher), 2009-11, Vol.63 (11), p.1578-1588

2009

Volltextzugriff (PDF)

P.3.c.021 Patterns of antipsychotic-induced weight change: 3-year results from the intercontinental schizophrenia outpatient-health outcomes (IC-SOHO) study

European neuropsychopharmacology, 2006, Vol.16, p.S407-S408

2006

Volltextzugriff (PDF)

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

Archives of general psychiatry, 2002-05, Vol.59 (5), p.441

2002

Volltextzugriff (PDF)

Safety and efficacy of olanzapine in treating patients with schizophrenia

Schizophrenia research, 2003-03, Vol.60 (1), p.273-274

2003

Volltextzugriff (PDF)

Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study

Current therapeutic research, 2004, Vol.65 (1), p.57-69

2004

Volltextzugriff (PDF)

P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial

European neuropsychopharmacology, 2003-10, Vol.13, p.S213-S213

2003

Volltextzugriff (PDF)

Olanzapine treatment after clozapine induced agranulocytosis

Human psychopharmacology, 1998-12, Vol.13 (8), p.583-584

1998

Volltextzugriff (PDF)

Olanzapine treatment after clozapine induced agranulocytosis

Human Psychopharmacology: Clinical and Experimental, 1998, Vol.13 (8), p.583-584

1998

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)
Berichte
(1)

Sprache

Englisch
(25)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(15)
Adult
(12)
Psychiatry
(12)
Female
(11)
Antipsychotic Agents - Therapeutic Use
(10)
Male
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Olanzapine
(8)
Pharmacology & Pharmacy
(8)
Schizophrenia - Drug Therapy
(8)
Treatment Outcome
(7)
Benzodiazepines
(6)
Middle Aged
(6)
Pharmacology. Drug Treatments
(6)
Pirenzepine - Analogs & Derivatives
(6)
Pirenzepine - Therapeutic Use
(6)
Psychology. Psychoanalysis. Psychiatry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial

Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss

Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients

An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms

Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

336 Matching-adjusted indirect comparisons of Ixekizumab and Secukinumab using Etanercept and Ustekinumab Bridge Comparators

Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol

Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study

Specificity of FGF signaling in cell migration in Drosophila

The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

P.3.e.003 The relative association between four treatment-emergent adverse events and health-related quality of life

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients: W-SOHO: observational database of more than 17,000 patients

P.3.c.021 Patterns of antipsychotic-induced weight change: 3-year results from the intercontinental schizophrenia outpatient-health outcomes (IC-SOHO) study

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

Safety and efficacy of olanzapine in treating patients with schizophrenia

Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study

P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial

Olanzapine treatment after clozapine induced agranulocytosis

Olanzapine treatment after clozapine induced agranulocytosis

Suchergebnisse filtern